Chlorzoxazone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00356 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 3 | migraine with brainstem aura | KG + DL |
| 4 | migraine with or without aura, susceptibility to | KG + DL |
| 5 | pulmonary hypertension | KG + DL |
| 6 | atrophoderma vermiculata | KG + DL |
| 7 | ulerythema ophryogenesis | KG + DL |
| 8 | kyphoscoliotic heart disease | KG + DL |
| 9 | rheumatoid arthritis | KG + DL |
| 10 | headache disorder | KG + DL |
| 11 | trigeminal autonomic cephalalgia | KG + DL |
| 12 | brachydactyly-syndactyly syndrome | KG + DL |
| 13 | neuroretinitis | KG + DL |
| 14 | Tourette syndrome | KG + DL |
| 15 | hypertrichosis (disease) | KG + DL |
| 16 | vestibular neuronitis | KG + DL |
| 17 | motor nerve neuritis | KG + DL |
| 18 | brachial plexus neuritis | KG + DL |
| 19 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 20 | fibromyalgia | KG + DL |
| 21 | tendinitis | KG + DL |
| 22 | myositis fibrosa | KG + DL |
| 23 | idiopathic granulomatous myositis | KG + DL |
| 24 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 25 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 26 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 27 | trichotillomania | KG + DL |
| 28 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 29 | isolated genetic hair shaft abnormality | KG + DL |
| 30 | inclusion body myositis | KG + DL |
| 31 | leprosy | KG + DL |
| 32 | nephrogenic diabetes insipidus | KG + DL |
| 33 | sciatic neuropathy | KG + DL |
| 34 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 35 | myofascial pain syndrome | KG + DL |
| 36 | diabetes insipidus, nephrogenic, X-linked | KG + DL |
| 37 | dysthymic disorder | KG + DL |
| 38 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 39 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 40 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 41 | idiopathic pulmonary arterial hypertension | KG + DL |
| 42 | thoracic malformation | KG + DL |
| 43 | nephrogenic diabetes insipidus-intracranial calcification syndrome | KG + DL |
| 44 | coxopodopatellar syndrome | KG + DL |
| 45 | pulmonary hypertension, primary | KG + DL |
| 46 | allergic asthma | KG + DL |
| 47 | subarachnoid hemorrhage (disease) | KG + DL |
| 48 | persistent Mullerian duct syndrome | KG + DL |
| 49 | obsessive-compulsive disorder | KG + DL |
| 50 | adult familial nephronophthisis-spastic quadriparesia syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.